The novel treatment of this peptide represents a exciting development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide043695.verybigblog.com/40783432/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment